Kwon, Byoung Soo, et al. "Survival benefit of first-generation epidermal growth factor receptor–tyrosine kinase inhibitors in female with advanced lung cancer." Tumori Journal (2019): 0300891619839292. https://www.ncbi.nlm.nih.gov/pubmed/30905312
